Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Retatrutide is a novel triple hormone agonist that simultaneously activates GIP, GLP-1, and GCG receptors
How long before I may notice improvements
A randomized, phase 3, open-label trial comparing the effect of the addition of tirzepatide once weekly versus insulin lispro (U100) three times daily in participants with type 2 diabetes inadequately controlled on insulin glargine (U100) with or without metformin (SURPASS-6)
E., Van Gelder, I
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
